Uncommon GNAQ, MMP8, AKT3, EGFR, and PIK3R1 Mutations in Thyroid Cancers
- 13 April 2011
- journal article
- research article
- Published by Springer Science and Business Media LLC in Endocrine Pathology
- Vol. 22 (2), 97-102
- https://doi.org/10.1007/s12022-011-9155-x
Abstract
Frequent mutations in the GNAQ, MMP8, Akt3, EGFR, and PIK3R1 genes have been reported in human cancers but mostly have not been well examined in thyroid cancer. Selected exons of GNAQ, MMP8, AKT3, EGFR, and PIK3R1 genes were sequenced in various thyroid cancers. We found a G2203A EGFR mutation, resulting in a G735S amino acid change, in one of 21 (5%) papillary thyroid cancer samples. We did not find any mutation in the MMP8 gene, but observed a frequent SNP A259G (K87E) genotype switch in various types of thyroid cancer samples. We did not find any mutation in the GNAQ, AKT3, and PIK3R1genes in various types of thyroid cancer. No mutation in these genes was found in 12 cell lines derived from various types of thyroid cancer. Therefore, unlike in other cancers, mutations in these genes are uncommon in thyroid cancer.This publication has 22 references indexed in Scilit:
- Analysis of the matrix metalloproteinase family reveals that MMP8 is often mutated in melanomaNature Genetics, 2009
- Epidermal growth factor receptor gene mutations in papillary thyroid carcinomaInternational Journal of Cancer, 2008
- Frequent somatic mutations of GNAQ in uveal melanoma and blue naeviNature, 2008
- A novel AKT3 mutation in melanoma tumours and cell linesBritish Journal of Cancer, 2008
- Highly Prevalent Genetic Alterations in Receptor Tyrosine Kinases and Phosphatidylinositol 3-Kinase/Akt and Mitogen-Activated Protein Kinase Pathways in Anaplastic and Follicular Thyroid CancersJournal of Clinical Endocrinology & Metabolism, 2008
- Thyroid cancer incidence and socioeconomic indicators of health care accessCancer Causes & Control, 2008
- Epidermal growth factor receptor activation in prostate cancer by three novel missense mutationsOncogene, 2008
- Epidermal Growth Factor Receptor as a Therapeutic Target in Human Thyroid Carcinoma: Mutational and Functional AnalysisJournal of Clinical Endocrinology & Metabolism, 2006
- Genetic Heterogeneity of the Epidermal Growth Factor Receptor in Non–Small Cell Lung Cancer Cell Lines Revealed by a Rapid and Sensitive Detection System, the Peptide Nucleic Acid-Locked Nucleic Acid PCR ClampCancer Research, 2005
- Erlotinib in Lung Cancer — Molecular and Clinical Predictors of OutcomeThe New England Journal of Medicine, 2005